BioLASCO Taiwan Co. Ltd.(TW:6662)
NT$28.400.00 (0.00%)
TW:6662
BioLASCO Taiwan Co. Ltd. financials statements
NT$28.40
At close:0.00 (0.00%)
BioLASCO Taiwan Co. Ltd. (6662) Financial Statements
BioLASCO Taiwan Co. Ltd. Financial Overview
BioLASCO Taiwan Co. Ltd.'s market cap is currently NT$727.39M. The company's EPS TTM is NT$1.60; its P/E ratio is 17.75; and it has a dividend yield of 5.46%. BioLASCO Taiwan Co. Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 262.66M | NT$ 292.50M | NT$ 264.72M | NT$ 235.91M | NT$ 227.58M |
| Gross Profit | NT$ 101.62M | NT$ 114.76M | NT$ 104.35M | NT$ 104.49M | NT$ 105.11M |
| Operating Income | NT$ 48.04M | NT$ 55.71M | NT$ 50.76M | NT$ 54.22M | NT$ 57.35M |
| EBITDA | NT$ 59.58M | NT$ 67.64M | NT$ 73.86M | NT$ 59.50M | NT$ 67.34M |
| Net Income | NT$ 42.43M | NT$ 44.03M | NT$ 49.74M | NT$ 42.31M | NT$ 45.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 136.41M | NT$ 162.52M | NT$ 201.67M | NT$ 227.20M | NT$ 244.47M |
| Total Assets | NT$ 592.58M | NT$ 612.67M | NT$ 573.14M | NT$ 569.69M | NT$ 574.26M |
| Total Debt | NT$ 93.58M | NT$ 107.01M | NT$ 58.21M | NT$ 65.94M | NT$ 69.18M |
| Net Debt | NT$ 12.88M | NT$ 189.00K | NT$ -84.76M | NT$ -102.56M | NT$ -131.99M |
| Total Liabilities | NT$ 134.86M | NT$ 163.29M | NT$ 111.98M | NT$ 115.05M | NT$ 113.91M |
| Stockholders' Equity | NT$ 457.72M | NT$ 449.38M | NT$ 461.16M | NT$ 454.64M | NT$ 460.36M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 27.06M | NT$ 931.00K | NT$ 27.83M | NT$ 40.42M | NT$ 66.49M |
| Operating Cash Flow | NT$ 48.71M | NT$ 56.86M | NT$ 29.46M | NT$ 44.69M | NT$ 70.84M |
| Investing Cash Flow | NT$ -20.32M | NT$ -97.60M | NT$ -8.83M | NT$ -28.72M | NT$ -13.17M |
| Financing Cash Flow | NT$ -54.50M | NT$ 4.59M | NT$ -46.16M | NT$ -48.63M | NT$ -57.97M |
Currency in TWD
